Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
291 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (5%) | |
| Resolved: | 271 (93%) | |
Discontinuation Reports |
61 |
|
| To be discontinued: | 7 (11%) | |
| Discontinued: | 53 (87%) | |
| Reversed: | 1 (2%) | |
Late reports |
21 (6%) |
|
Overdue reports |
5 (45%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUDARA | 10MG | TABLET | Resolved | 2022-08-25 | 2023-04-13 | 167783 |
| FLUDARA | 10MG | TABLET | Resolved | 2025-11-27 | 2025-12-02 | 272579 |
| FLUDARA | 10MG | TABLET | Resolved | 2025-11-27 | 2025-12-02 | 272582 |
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2017-03-14 | 2017-03-20 | 2494 |
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2021-08-24 | 2021-08-25 | 144479 |
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2022-07-19 | 2022-11-30 | 165003 |
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2022-09-28 | 2022-11-30 | 170396 |
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2023-02-14 | 2023-06-23 | 184615 |
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2023-02-14 | 2023-06-23 | 184642 |
| GLUCOPHAGE | 500MG | TABLET | Resolved | 2023-07-19 | 2023-09-01 | 199227 |
| GLUCOPHAGE | 850MG | TABLET | Resolved | 2019-02-20 | 2019-07-19 | 76402 |
| GLUCOPHAGE | 850MG | TABLET | Resolved | 2022-01-21 | 2022-03-30 | 153372 |
| GLUCOPHAGE | 850MG | TABLET | Resolved | 2022-12-14 | 2023-09-01 | 178385 |
| IMOVANE | 5.0MG | TABLET | Resolved | 2018-04-10 | 2019-03-08 | 45394 |
| IMOVANE | 7.5MG | TABLET | Resolved | 2018-12-06 | 2019-02-15 | 68864 |
| JEVTANA | 40MG | SOLUTION | Avoided shortage | 2019-06-27 | 2019-07-19 | 87765 |
| KAYEXALATE | 100% | POWDER | Resolved | 2019-01-15 | 2019-02-06 | 72245 |
| KAYEXALATE | 100% | POWDER | Resolved | 2019-04-23 | 2019-05-24 | 82271 |
| KAYEXALATE | 1G | POWDER FOR SUSPENSION POWDER | Resolved | 2024-07-26 | 2024-08-01 | 233798 |
| KEVZARA | 200MG | SOLUTION | Resolved | 2022-11-08 | 2022-12-04 | 173986 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |
| RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
| RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
| RENVELA | 800MG | TABLET | Reversed | 2025-03-31 | 2025-09-26 | 253680 |
| RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
| RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
| RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
| SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
| SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
| SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
| TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
| TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
| TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
| TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
| TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
| TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
| ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |
| ZALTRAP | 200MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121390 |